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Volume 93  Number 4  2015 MRI of brain development after radiation 883therapy and conducted cor-
responding experiments in
mice. Radiation treatment
resulted in decreased white
matter volume and increased
cortical thickness in both
species. Decreasing hippo-
campal volume was observed
in patients after radiation but
not in mice, although
decreased growth and
volume were seen in the
mouse olfactory bulb.
Results highlight the causa-
tive role of radiation therapy
in impaired brain develop-
ment and support investiga-
tion using a mouse model.anatomical change can be established, and the effect of treatment age can be more
fully characterized. Anatomical results were compared between species.
Methods and Materials: Patients were imaged with T1-weighted magnetic resonance
imaging (MRI) after radiation treatment. Nineteen radiation-treated patients were
divided into groups of 7 years of age and younger (7) and 8 years and older (8þ)
and were compared to 41 controls. C57BL6 mice were treated with radiation
(nZ52) or sham treated (nZ52) between postnatal days 16 and 36 and then assessed
with in vivo and/or ex vivo MRI. In both cases, measurements of WM and GM vol-
ume, cortical thickness, area and volume, and hippocampal volume were compared be-
tween groups.
Results: WM volume was significantly decreased following treatment in 7 and
8þ treatment groups. GM volume was unchanged overall, but cortical thickness
was slightly increased in the 7 group. Results in mice mostly mirrored these changes
and provided a time course of change, showing early volume loss and normal growth.
Hippocampal volume showed a decreasing trend with age in patients, an effect not
observed in the mouse hippocampus but present in the olfactory bulb.
Conclusions: Changes in mice treated with cranial radiation are similar to those in hu-
mans, including significant WM and GM alterations. Because mice did not receive any
other treatment, the similarity across species supports the expectation that radiation is
causative and suggests mice provide a representative model for studying impaired
brain development after cranial radiation and testing novel treatments.  2015 The
Authors. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Cranial radiation therapy (CRT) is an integral component of
treatments for brain tumors and some high-risk forms of
leukemia but is directly associated with late effects (1-3),
which manifest years after treatment as cognitive, endo-
crine, or other dysfunctions (4, 5). Increased radiation dose
is a significant risk factor for decreased intelligence quotient
(IQ), reduced academic performance, and impairments in
measurements of processing speed, memory, and executive
function (6-9). Magnetic resonance imaging (MRI)
measurements have identified reduced white matter (WM)
volume, altered WM structure, and possible changes in
hippocampal volume due to CRT (10-12). These measure-
ments correlate with behavioral outcomes (12-15), sug-
gesting an intuitive link between normal brain development
and proper brain function. Understanding, preventing, and
treating late effects are important research priorities (9, 16).
The mouse provides a controlled experimental model
with which to characterize CRT effects that eliminates
some of the challenges inherent in clinical studies. The
mouse can be treated with CRT exclusive of other possible
treatments or cancer effects, and outcome can be assessed
over relatively short time periods (weeks to months instead
of years to decades). Radiation treatment in mice also re-
sults in behavioral abnormalities, including impaired
learning and memory that has been associated with reduced
hippocampal neurogenesis (17-19). As may be expected
(20, 21), anatomical changes through development are also
present (22) with a dependence on age, dose, and sex (23),
reminiscent of known risk factors in human patients (9, 24).Provided it is representative of the effects seen in patients,
the mouse model will enable efficient study of late effect
mechanisms and treatments to mitigate them.
Our purpose in this study was to perform a side-by-side
evaluation of radiation-induced neuroanatomical changes in
humans and mice. First, we expected this would allow an
expanded evaluation of brain structure changes in patients,
confirming expectations in WM and expanding to assess
gray matter (GM) as well, particularly the cortex and hip-
pocampus. Second, we wished to determine the extent to
which phenotypes in mice mirrored these findings. This
allowed isolation of the CRT effects from other clinical and
treatment factors, provided additional insight into the
possible time course of changes seen in patients, and
permitted evaluation of the mouse model.Methods and Materials
Human data
The data set included 144 T1-weighted MRI scans collected
from 60 children, including 32 healthy controls, 9 surgical
controls (in whom no CRT was performed, but 2 patients
received chemotherapy), and 19 CRT patients. Each patient
received 1 to 4 scans (average, 2.4 scans) with an average
scan age of 11.2 years. The 19 CRT patients were divided
into 2 groups based on age at diagnosis, consisting of
those 7 years of age and younger (7) and 8 years of age
and older (8þ; nZ11 and 8 patients, respectively).
Figure 1a and Supplementary Table 1 (available online at
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Fig. 1. Timelines for human and mouse imaging studies.
(a) Each row shows a subject in the Control, Surgical
Control, diagnosis at 7 and under (7), or diagnosis at 8 and
over (8þ) group. Imaging time points (MRI) are shown
with black dots, and diagnosis age is shown with an x. Lines
connect scans collected longitudinally. (b) An equivalent
timeline for the mouse experiments is also shown. A lon-
gitudinal study (bottom lines) was conducted in vivo with
cranial radiation therapy (CRT) or sham at postnatal day 16
(P16). Additionally, a series of groups were evaluated
ex vivo after treatment at different ages. The latter were
grouped into infancy (INF), early-childhood (EC), and late
childhood (LC). Abbreviations: d Z days; y Z years.
Nieman et al. International Journal of Radiation Oncology  Biology  Physics884www.redjournal.com) provide further information. The
majority of CRT patients (14 of 19) received a total cra-
niospinal dose of 23.4 Gy; 1 patient received 30.6 Gy and 4
received 36 Gy. Total dose to the posterior fossa was
boosted to 54 Gy (4 patients), 55.8 Gy (14 patients), or
59.4 Gy (1 patient). Analyses of single time point data and
other image contrasts (ie, diffusion images) have been
reported previously for a subset of the patients and controls
used in the present cohort (12, 25, 26).
From image data, we computed total and lobe-specific
WM and GM volumes, cortical thicknesses, and hippo-
campal volumes. MRI results were fitted with a linear
mixed effects model with a coefficient for age at scanning
and a coefficient representing a constant offset for each of
the 7 and 8þ CRT groups. Variability among patients was
accounted for with a subject-specific random intercept term.
In each case, the significance of an additional coefficient for
time since diagnosis was also tested. Supplementary
materials (available online at www.redjournal.com) pro-
vide additional details of the imaging and analysis methods
(25, 27-36). Where multiple statistical comparisons were
performed, significance was tested after adjustment of the P
value by using the false discovery rate (FDR; referring to
the adjusted value as the Q value).
Mouse experiments
We compared human results to observations in a mouse
model of CRT (22, 23). All mouse experiments wereapproved by the Toronto Centre for Phenogenomics Animal
Care Committee. Acquisition of image data was previously
described (23). Briefly, C57BL/6J mice were irradiated
with 0 or 7 Gy at a single time point between postnatal day
16 (P16) and P36. Assuming a linear quadratic model (with
an a/b ratio of 2 Gy), this dose is considered equivalent to
w16 Gy delivered in 2-Gy fractions. Due to the rapid rate
of mouse development and to limit effects from frequent
handling, a fractionated delivery was not used. To facilitate
comparison with patient data, treatment ages for mice were
combined into infancy (INF) (P16-P18), early childhood
(EC) (P20-P26), and late childhood (LC) (P29-P36) treat-
ment groups. From the MR images, we computed WM and
GM volumes, cortical thicknesses, and brain structure
volumes based on an existing atlas (which included hip-
pocampal volume) (40). In vivo data were fitted with a
linear mixed effects model, with mouse-specific random
intercept coefficients and fixed coefficients representing
normal development by a spline and a treatment-dependent
deviation with coefficients for a constant offset and a slope
linear in age. Ex vivo data were fitted with a simple linear
model, fitting a spline in treatment age to the deviation from
the mean control volume. Additional experimental details
can be found in Figure 1b and supplementary materials
(available online at www.redjournal.com) (37-41).
Results
WM volume is decreased following pediatric CRT
In both the 7 and 8 þ CRT patient groups, we observed a
smaller total (supratentorial) WM volume than in controls
(P<.01 and P<.05, respectively) (Fig. 2a, b). WM volumes
in surgical controls did not differ from healthy controls
(PZ.87) and were grouped together for all analyses.
Frontal, parietal, temporal, and occipital lobe WM volumes
were significantly smaller in the 7 CRT group on both
sides of the brain (Q < .05) (Fig. 2e, f). The 8 þ CRT group
also showed decreased volumes (Q < .05), except in the left
temporal and left occipital lobes (QZ.07 and .17, respec-
tively). Time since diagnosis did not contribute to a model
of the WM volume results, suggesting that the WM volume
was present prior to the first post-treatment scans.
Substantiating observations of WM in humans,
radiation-treated mice showed decreased WM volume. The
volume decrease occurred early after CRT and was fol-
lowed by a growth rate comparable to that in untreated
mice, resulting in a persistent volume deficit (Fig. 2c).
Treatment at later ages resulted in more normal total WM
volumes (Fig. 2d), with no differences apparent when CRT
occurred in the LC stages.
Changes in cortical GM after pediatric CRT
Total GM volume in humans was not substantially different
between control and CRT groups (Fig. 3a). More detailed
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Fig. 2. White matter volume is decreased after cranial radiation therapy (CRT). Total white matter (WM) volume was
computed for all patient images (a). The fit of the linear mixed effects model (shaded red for control [CTL] group) was used
to compute a volume for each patient, normalized to 11.2 years (y) of age. (b) This normalized volume is plotted against age
at diagnosis. Volume is significantly decreased in both the 8þ and 7 groups (P<.05 and P<.01, respectively). CRT in mice
provided more comprehensive coverage of treatment and imaging ages. (c, d) Each point represents the group mean for all
mice for that time point, with pooling into infancy (INF), early childhood (EC), and late childhood (LC), indicated by color
coding (d). (c) In mice, a WM volume decrease of w7% was observed by the first imaging time point after treatment
(P<.0001), which persisted to adulthood. (d) The degree of deficit decreased when treatment was delayed to later ages, with
INF (QZ3e-5) and EC (QZ.003) but not LC groups showing significant differences. (e) Separation of human WM into
frontal (F), parietal (P), occipital (O), and temporal (T) lobes allowed comparison of lobe volumes. (f) Both of the patient
groups showed significant volume differences (Q < .05 for 8þ and Q < .01 for 7, right side shown). Occipital and temporal
lobe WM volume differences did not reach significance on the left side (QZ.17 and .07 respectively). Shaded areas and error
bars show 95% confidence intervals (*P<.05, **P<.01; yQ < .1, yyQ < .01). A color version of this figure is available at
www.redjournal.org.
Volume 93  Number 4  2015 MRI of brain development after radiation 885analysis of the cortical GM revealed that, in the 7 CRT
group, average cortical thickness was slightly increased in the
frontal, occipital, and temporal lobes (Q < .1) but not sig-
nificantly in the parietal lobe (Fig. 3b). No significant differ-
ences in cortical thicknesses were observed in the 8 þ group.Total GM volume in treated mouse brains showed a
modest decrease relative to that of controls (Fig. 3c), which
persisted unchanged throughout development. Average
measurements of mouse cortical thicknesses across each
lobe revealed only a small increase in the occipital lobe
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Fig. 3. Cortical gray matter (GM) is altered after cranial radiation therapy (CRT). Total GM volume was computed for all
patient images (a) and was not significantly different between treated and untreated groups. (b) Analysis of cortical thickness
showed increased thickness in the 7 group in the frontal, occipital, and temporal lobes (Q < .1) but not in the parietal lobe.
(c) Total gray matter over time after CRT at P16 in the mouse is shown. An initial 5% drop is observed (PZ.0002), but
subsequent growth over time was not different from that of controls. (d) Measurements of cortical thickness in the frontal,
parietotemporal, and occipital lobes are shown. An increase in thickness was observed only in the occipital lobe after
treatment in infancy (QZ.03) but not significantly in the frontal and parietotemporal lobes (QZ.14 and .29, respectively).
Additional cortical thickness results are shown in Fig. 4 (yQ < .1).
Nieman et al. International Journal of Radiation Oncology  Biology  Physics886(QZ.03) (Fig. 3d). However, more localized analysis
showed that the ventral orbital cortex was thicker in treated
mice (Fig. 4). Thickness differences appeared shortly after
treatment and grew over time (largely due to thinning in
controls after w P42) (Fig. 4b). This change in cortical
thickness was present in treatments at INF and EC (QZ8e-
5 and .04, respectively), but was eliminated when treatment
was delayed to LC (Fig. 4c).
We also evaluated cortical surface area and volume in
humans and mice (Fig. 5). In human data, we detected no
statistical differences between these parameters after mul-
tiple comparison correction, although there may be a trend
toward decreased surface area. Similar measurements in the
mouse showed a cortical surface area decrease only in the
INF group (QZ.003, .004, and .003 for frontal, parieto-
temporal, and occipital lobes, respectively) (Fig. 5c) and no
differences in total cortical volume. In human data, we also
computed the gyrification index (42), which showed nodifferences, and the ratio of the square root of the surface
area to the thickness (a cortical aspect ratio, with larger
values representing thinner sheets with larger areas). This
measure was significantly reduced in the frontal, occipital,
and temporal lobes (Q < .05) on both sides of the brain in
the 7- group and in the parietal lobes to a lesser degree
(QZ.16 and QZ.04 for left and right sides, respectively).
Decreased hippocampal volume after CRT
We further investigated GM by assessing total hippocampal
volume, which did not show a significant dependence on
treatment group (Fig. 6a, b). However, addition of time
since CRT to the model for patient groups showed a sig-
nificant negative term (P<.01), indicating a decreasing
hippocampal volume post treatment in CRT patients
(Fig. 6c). Relative to the hippocampal volume of controls
(which was modestly increasing at a rate of 28 mm3/year;
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thickness. (a) Segmentation of the orbital area (OA) in the
mouse brain is shown, along with the frontal (F), parieto-
temporal (PT), and occipital (O) lobes. On the right side of
the lower panel in (a), a map of significantly different
thickness measurements due to cranial radiation therapy
(CRT) at P16 is shown, where Q < .01 for each vertex of
the surface (otherwise colored white). (b) Average cortical
thickness over the OA is shown longitudinally, indicating
an increasing thickness relative to that of controls (CTL) to
early adulthood. (c) OA thickness is shown after CRT at
different ages. Significant differences after CRT were
detected after treatment in infancy (INF) (QZ8e-5) and
early childhood (EC) (QZ.04) but not late childhood (LC).
Error bars and shaded areas show 95% confidence intervals
(yQ < .1, yyQ < .01).
Volume 93  Number 4  2015 MRI of brain development after radiation 887P<.02), this amounted to a relative decrease in volume of
99 mm3/year (or w3% volume decrease relative to
controls).
In the mouse model, hippocampal volume showed an
early volume decrease after CRT in the INF group
(Fig. 6d) but not in the EC or LC group (Fig. 6e). Like
much of the mouse brain and unlike the human hippo-
campus, this difference persisted without significant
change (Fig. 6f). We also evaluated the volume time
course of the olfactory bulb, another structure with sig-
nificant neural progenitor cell input. It showed an imme-
diate volume decrease post-CRT (Fig. 6g) that depended
on age at treatment (Fig. 6h). In addition, the olfactory
bulb showed a progressive volume deficit resulting from a
decreased growth rate relative to controls (Fig. 6i, INF),
more reminiscent of the growth changes observed in the
human hippocampus.Discussion
The results we observed indicate significant changes in
both WM and GM after CRT. The WM changes were ex-
pected from previous reports (10, 15, 43). Supplementing
the human observations with experiments in mice sup-
ported the possibility that the WM volume loss occurs very
early after CRT and then does not recover during devel-
opment. This observation may indicate that normalization
of late effects related to WM loss would require an early
intervention and/or a strategy for protecting WM during
CRT.
We observed cortical and hippocampal GM alterations.
Normal cortical development includes an early growth and
a subsequent volume decrease with a peak thickness at 7 to
11 years of age (44-46). Thickness changes through
adolescence (as seen on MRI) are normally influenced by
synaptic pruning (47) and underlying white matter myeli-
nation (44). However, as most of the initial scans had been
acquired within a year or two of treatment, the cortical
differences we observed appeared to develop relatively
quickly, which might suggest inflammation, gliosis, or
other abnormal processes initiated by CRT. Moreover, it
seems likely that the changes in cortical thickness and WM
volume are related (48), but which is the most important in
manifesting late effects still needs to be determined. In
addition, we noted that the changes in average cortical
thickness that we observed after CRT were opposite to
those reported previously (49), indicating need for further
verification.
We also observed loss of w2% per year in the total
volume of hippocampus in CRT patients (vs w1%/year
growth in controls). In the adult human hippocampus, there
is an estimated 3.5% per year and 1.75% per year turnover
in non-neuronal and neuronal cell populations, respectively
(in which an estimated 50% and 33%, respectively, of total
cell populations are affected) (50). Decreasing hippocam-
pal volume after CRT may result from normal cell loss
combined with a reduced capacity to generate new cells for
replacement and ongoing growth. In the mouse, we
observed an early volume decrease of w5% after CRT,
with no change in growth rate. The fact that we did not
detect an early volume decrease in the human hippocam-
pus may be a simple question of sensitivity (given the
standard deviation of w10% in human hippocampal
volumes, we had only enough statistical power to detect
differences of w10%, assuming a power of 0.8 and a
significance of .05). Differences in post-treatment hippo-
campal growth rates between species, however, are likely a
real effect, and may be due to species differences in the
rate and population of cells subject to turnover. Relative to
the rate of cell replacement in humans, the mouse has a
limited number of cells being replaced at a faster rate (eg,
w10% of mouse hippocampal neurons are replaced in
w4 months [51]). Like the human hippocampus, the
mouse olfactory bulbs exhibited a progressive volume
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Fig. 5. Additional cortical geometry measurements. Measurements of total cortical surface area (a) and cortical volume (b)
were made for each lobe (right side shown unless indicated). No differences reached significance. Similar measurements in
the mouse (c, d) showed a decrease in cortical surface areas ofw4% after treatment in infancy (QZ.003, .004 and .003 for
frontal, parietotemporal and occipital lobes) but not at later treatment ages. In humans, the gyrification index (e) also showed
no significant differences at the white matter [WM] or the gray matter [GM]. Comparisons of the root of the surface areas
over the thickness (an aspect ratio that is large for thin sheets) showed that all lobes were different in the 7 patient group
(Q < .05) (f). Error bars in all cases show 95% confidence intervals (yQ < .1, yyQ < .01).
Nieman et al. International Journal of Radiation Oncology  Biology  Physics888deficit after CRT. Although the granule cell layer of the
mouse olfactory bulb has properties similar to those of the
hippocampus, the glomerular layer turns over at the rate of
w40%/year (51). These differences in cellular kinetics
may determine the species-specific changes in growth after
CRT.
Overall, mouse model data showed substantial parallels
to those of the humans in WM volume and GM cortical
outcome measurements (although the latter were more
localized). Nonetheless, we noted that the mouseexperiments could not entirely mimic the human case and
that treatment differences between species might have
affected outcomes. First, the short developmental time
course in mice is incompatible with the fractionated doses
used in patients, which in the mouse would span from in-
fancy well into puberty if used unaltered. As an alternative,
we delivered CRT to mice in a single fraction that provides
a temporally localized radiation insult and allows brain
development to progress undisturbed thereafter. Different
doses or fraction schedules are likely to alter some aspects
a b c
d e f
g h i
4.0
3.5
3.0
2.5
4.0
3.5
3.0
2.5
5 10 15
puberty
puberty
puberty
Control
Control
Surg. Only
8+
7-
Age (y)
Age (d)
Age (d)
H
um
an
 H
ip
po
ca
m
pa
l
Vo
lu
m
e 
(1
03
 m
m
3 )
M
ou
se
 H
ip
po
ca
m
pa
l
Vo
lu
m
e 
(m
m
3 )
M
ou
se
 O
lfa
ct
or
y 
Bu
lb
Vo
lu
m
e 
(m
m
3 )
M
ou
se
 O
lfa
ct
or
y 
Bu
lb
Vo
lu
m
e 
(m
m
3 )
M
ou
se
 H
ip
po
ca
m
pa
l
Vo
lu
m
e 
(m
m
3 )
H
um
an
 H
ip
po
ca
m
pa
l
Vo
lu
m
e 
(1
03
 m
m
3 )
Di
ff
er
en
ce
 f
ro
m
 C
on
tr
ol
 F
it
 (
10
3  
m
m
3 )
Di
ff
er
en
ce
 f
ro
m
 C
on
tr
ol
 F
it
 (
m
m
3 )
Di
ff
er
en
ce
 f
ro
m
 C
on
tr
ol
 F
it
 (
m
m
3 )
CTL 8+ 7-
1.0
0.5
0.0
-0.5
-1.5
-1.0
0 2 4 6 8
Years Since Treatment
20
19
20
19
18
17
16
14 24 42 63 98 CTL LC EC INF
CTL LC EC INF
1
0
-1
-2
-3
7 28 49 84
7 28 49 84
Days Since Treatment
Days Since Treatment
Infancy
25.0
22.5
20.0
14 24 42 63 98
25
24
23
22
-2
-4
-6
†
†
Fig. 6. Hippocampal volume and growth after cranial radiation therapy (CRT). Total hippocampal volume, shown for all
patient images (a), showed no significant differences between controls (CTL) and either of the patient groups. This is viewed
after normalization to 11.2 years (y) (b). Hippocampal volume was observed to grow in CTL (95% confidence intervals in red
for fit line [a]). In the treated goups, however, a decreasing volume with time since treatment was observed. (c) Deviation
from the control fit is shown for each patient, with time since treatment on the horizontal axis for both the 7 and the
8þ groups. The black line shows the fit (common to the 7 and 8þ groups) with 95% confidence intervals. In the mouse,
hippocampal volume showed an initial volume decrease (Q < .05) after CRT at P16 (d), but then growth was normal, with no
differences from that of controls (f). Hippocampal volume comparisons between groups of mice was significant only in the
infant (INF) treatment group (QZ.02) (e). The olfactory bulb, another region of active neurogenesis in the mouse, also
showed an initial volume decrease (Q < .05) (g). Significant group differences were seen only in the INF treatment group (h)
(QZ.0004). EC Z early childhood; LC Z late childhood. In the olfactory bulb, growth after treatment was also altered
(0.03 mm3/day relative to that of controls) (i). (yQ < .1). A color version of this figure is available at www.redjournal.org.
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whole brain in the mice, although patients received a
spatially heterogeneous dose with a boost to the posteriorfossa. More recent tools for focal irradiation in the mouse
would allow more accurate replication of such a distribu-
tion (52). Third, we noted that the anatomy of the mouse
Nieman et al. International Journal of Radiation Oncology  Biology  Physics890brain is quite different, with little white matter and a flat
cortical geometry, and that the mice did not have pre-
existing tumors at treatment. The latter is a considerable
advantage of the mouse model because the effect of CRT
can be separated from cancer effects in a way not possible
in patients. Despite these human-mouse differences, our
MRI data indicate significant parallels between species
after CRT.
Conclusions
In conclusion, this study confirmed significant loss of WM
after CRT in pediatric patients and also revealed an increase
in cortical thickness and a decreasing hippocampal volume.
A mouse model in which CRT is provided in a single dose,
in the absence of ancillary treatment or disease, mimicked
many of these features and suggests some changes occur
very early after treatment. Further experiments in mice will
permit testing of late effect interventions or possible
treatment modifications. Results also highlighted some
species differences that necessitate careful interpretation
when translating to patients.
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